The management of severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis

Archives of Dermatology

Volumn 145, Issue 11, 2009, Pages 1336-1337

  Sotozono, Chie ^a   Ueta, Mayumi ^a   Kinoshita, Shigeru ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ANKYLOBLEPHARON; CORNEA EPITHELIUM; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EYE DISEASE; HUMAN; LETTER; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; VISUAL IMPAIRMENT;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; EPIDERMAL NECROLYSIS, TOXIC; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME;

EID: 72749085051     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.293     Document Type: Letter

References (5)

1. Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009;145(2):157-162.
2. Sotozono C, Ueta M, Koizumi N, et al. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology. 2009;116(4):685-690.
3. Araki Y, Sotozono C, Inatomi T, et al. Successful treatment of Stevens-Johnson Syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol. 2009;147(6):1004-1011.
4. Sotozono C, Ang LP, Koizumi N, et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology. 2007;114(7):1294-1302. (Pubitemid 47001496)
5. Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM. Existence of slowcycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989;57(2):201-209. (Pubitemid 19112360)